Calendar of Events
Featured Speaker: AnnaMarie Connolly, MD, FACOG – “We Can All Agree: No One Starts the Day Wanting to Do a Bad Job – Getting to Our Best Days Through Critical Thinking, Feedback, and Innovation”
Chief of Education and Academic Affairs for the American College of Obstetricians and Gynecologists (ACOG)
About Dr. Connolly
Dr. Connolly obtained her MD from Tufts University. After completing her residency in OBGYN at the University of North Carolina (UNC), she worked as a specialist in private practice for 2 years. She then returned to UNC and completed a fellowship in Urogynecology/Reconstructive Pelvic Surgery. Dr. Connolly continued her career at UNC where she was named the Annie Louise Wilkerson, MD ’36 Distinguished Professor, served as the Obstetrics and Gynecology clerkship director for 7 years, Residency Program Director for 11 years, the Fellowship Program Director for the Female Pelvic Medicine and Reconstructive Surgery Fellowship for 4 years and was also the Vice Chair for Education in the department of OBGYN. She is now the chief of education and academic affairs of ACOG.
While her clinical experience focused on urogynecology, her primary academic interests include medical education and the effect of childbirth on the pelvic floor. She has published original research on educational and clinical programming and tool development.
Her commitment to clinical practice and medical education has been recognized by the UNC School of Medicine. This includes her Directorship of the UNC Teaching Scholars Program for the past 13 years. Dr. Connolly has been honored for her educational efforts with multiple awards throughout her career at UNC. She is nationally recognized for her leadership in medical education.
Learn more about the E. James Aiman, MD, Endowed Lectureship
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]Resident and Fellow Research and Alumni Day is an annual event where our residents and graduating fellow present their clinical, translational science, and educational research results within their residency and fellowship in the Department of Obstetrics and Gynecology.
Featuring The Roland S. Cron Lectureship
Guest Speaker
Kristyn Melíssa Brandi, MD, MPH
Board Chair
Physicians for Reproductive Health
About Dr. Brandi
Dr. Kristyn Brandi (pronouns: she/her/ella) is an Assistant Professor at Rutgers – New Jersey Medical School, where she completed her medical school and residency. She completed a Family Planning Fellowship at Boston University where she also earned her Master’s in Public Health with a concentration in Health Law, Bioethics and Human Rights. Her research is on reproductive decision making, contraceptive coercion, and racism in reproductive health care. She serves as the Board Chair of Physicians for Reproductive Health, sits on several sub-committees for the Society of Family Planning and is a founding member of Centering Equity, Racial and Cultural Literacy in Family Planning (CERCL-FP). She proudly identifies as a Latina pansexual abortion provider.
Agenda
| Time | Activity |
|---|---|
| 7:15am | GRAB AND GO BREAKFAST |
| 7:45am | WELCOME & INTRODUCTIONS |
| 8:00am | Christine Livergood, MD, MFM Fellow Characterization of RhoBTB1, a PPARγ target gene, in the Placenta Mentors: Curt Sigmund, PhD & Jenn McIntosh, MD |
| 8:15am | Jordan Hauck, DO, R3 Risk of unplanned healthcare utilization in post-partum period for patients with hypertensive disorders of pregnancy Mentor: Anna Palatnik, MD |
| 8:30am | Leigh Mahlum, MD, R3 Factors associated with persistent hypertension at 1-year postpartum in patients with gestational hypertension or preeclampsia Mentor: Anna Palatnik, MD |
| 8:45am | Sarah Amherdt, MD, R3 Incidence of adverse pregnancy outcomes based on the degree of short interpregnancy interval in urban Milwaukee population Mentor: Anna Palatnik, MD |
| 9:00am | Zack Schoppen, MD, R3 What To Expect When You’re Expecting a Medical Student Mentor: Kate Dielentheis, MD |
| 9:15am | Steph Nguyen, MD, R3 Continuity of Care and Non-Urgent Health Care Utilization Mentors: Jessica Francis, MD & Stephen McAvoy, MD |
| 9:30am | BREAK |
| 9:45am | Alex Petrie, MD, R3 Evaluating the use and utility of a Weight Loss Clinic referral after surgical treatment of Endometrial Cancer Mentor: Erin Bishop, MD |
| 10:00am | Katie Pellino, MD, R3 Post-Discharge Opioid Prescribing After Cesarean: A Quality Improvement Initiative Mentor: Erika Peterson, MD |
| 10:15am | David Eggert, DO, R2 The Influence of Patient Education Level, Infertility Treatment, and Pregnancy and Breastfeeding Status on Perceptions of the COVID-19 Vaccine: A Mixed Methods Study Mentor: Stephanie Gunderson, MD |
| 10:30am | Rebecca Sigourney, MD, R2 Investigating the Impact of the Addition of a MIGS Surgeon on Surgical Volume of General OBGYNs Mentor: Ben Beran, MD |
| 10:45am | BREAK |
| 11:00am | The Roland S. Cron Lecture: Kristyn Melíssa Brandi, MD, MPH Title: "Who is in Control Here- Contraceptive Coercion and Reproductive Justice" |
Featured Speaker: Isabel C. Green, MD, MEHP
“Not Just SIM-antics: Maximizing Simulation for Surgical Skills”
About Dr. Green
Dr. Green completed her Obstetrics & Gynecology residency at John Hopkins University and fellowship in Minimally Invasive Gynecologic Surgery at Georgetown University-MedStar. She serves as the Associate Program Director for the OB/GYN residency program at Mayo Clinic and directs a transition to residency course in the Mayo Medical School. She is also the Fellowship Director for Minimally Invasive Gynecology and a consultant of Minimally Invasive Gynecologic Surgery and Gynecology at Mayo Clinic.
Her practice interests are in office hysteroscopy and also the management of abnormal uterine bleeding, cervical dysplasia and chronic pelvic pain. Since residency she has been engaged in undergraduate and graduate medical education, with a focus in surgical education. In 2017 she completed a Masters of Education in the Health Professions from Johns Hopkins University.
Learn more about the E. James Aiman, MD, Endowed Lectureship
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Presented by
Hallgeir Rui, MD, PhD
WBCS Endowed Professor of Breast Cancer Research
Vice Chair of Research, Department of Pathology
Director of MCW Tissue Bank
Associate Director of Shared Resources, MCW Cancer Center
Medical College of Wisconsin
About
Hallgeir Rui, MD, PhD is internationally recognized for his research on hormone signaling in breast cancer, and has a strong track record of leadership, mentoring and collaboration. He is the WBCS Endowed Professor of Breast Cancer Research at the Medical College of Wisconsin (MCW), with his primary appointment in the Department of Pathology, and a secondary appointment to the Department of Pharmacology & Toxicology. In addition, Dr. Rui serves as the Associate Director of Basic Science and Shared Resources at the MCW Cancer Center. With his past experience as a Program Leader and Shared Resource Director at the NCI-designated Sidney Kimmel Cancer Center at Thomas Jefferson University, Dr. Rui brings valuable experience to the MCW Cancer Center efforts toward NCI-designation. Dr. Rui serves on the Breast Cancer Translational Research Committee of NRG Oncology.
A central focus of hisresearch is on molecular profiling of solid tumors, with published track record in malignancies of the breast, pancreas, prostate, colon, head and neck and melanomas. Key areas of interest are therapy-relevant protein expression, including pathway-activation status and tumor immunology-related markers, with development of better predictive markers and improved personalized cancer care as the overarching goal. Efforts are dedicated to improving methods and applications for quantitative, multiplex immunohistochemistry (IHC) for single-cell protein marker analyses – histocytometry – in solid tumors.
His laboratory invented novel ultrahigh density tissue arraying technology termed cutting-edge matrix assembly (CEMA) that overcomes limitations of core-based tissue arrays (US patent 8,349,584). Our laboratory, in collaboration with Dr. Kay-Uwe Wagner, developed novel prolactin-humanized NSG-Pro mouse strain for more accurate modeling and drug response testing of human breast cancer and other prolactin receptor-positive cancers, and my team has established a panel of new patient-derived breast cancer xenograft models in NSG-Pro mice.
Dr. Rui has extensive experience in facilitating multidisciplinary and collaborative program projects, including a concluded $6.7 million Promise Project Award funded by Susan G. Komen Foundation. Attesting to the productive use of immunofluorescence-based quantitative histocytometry and tissue arraying technologies for high-throughput application of innovative and nonstandard technologies for immunoprofiling of solid tumors, I led a multidisciplinary team that quantified levels of more than 100 therapy-relevant protein markers in nearly 3,000 breast cancer specimens, using tissue arrays and accompanying clinical data assembled and procured by a consortium of five institutions. As the leader of this consortium, I coordinated extensive efforts to combine tissue resources, data, equipment resources and broad areas of expertise.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]